In Situ Hybridization Market- Trending Factors Influencing the Market Shares Worldwide 2018-2024

Worldwide markets are poised to achieve continuing growth as In Situ Hybridization is used in diagnostic situations to analyze single cells inside tissue. Managing single cell diagnostics in real time, encouraging collaborative business efforts. Lowering transaction management costs is a key benefit.

In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs).

Request A Sample Copy Market Report @:
https://www.radiantinsights.com/research/in-situ-hybridization-market/request-sample

Advances in RNA in situ hybridization transform molecular detection with morphological context enabling new applications. Scientists use RNA ISH to extract data dimensions.

Immunohistochemistry (IHC) and RNA in situ Hybridization are widely used technologies sharing the unique capacity to analyze a marker at the single cell level while preserving the morphological context. In different situations, IHC and ISH are used in conjunction to validate data or provide complementary information.

In situ hybridization (ISH) is a powerful technique for localizing specific nucleic acid targets within fixed tissues and cells, allowing users to obtain temporal and spatial information about gene expression and genetic loci. While the basic workflow of ISH is similar to that of blot hybridizations-the nucleic acid probe is synthesized, labeled, purified, and annealed with the specific target-the difference is the greater amount of information gained by visualizing the results within the tissue.

The global market for In Situ Hybridization (ISH) at $4.3 billion in 2017 is anticipated to reach $7.8 billion by 2024 2017. CAGR of 7.8% in the next five years (2017 to 2024). Increasing diagnosis and growing incidence & prevalence of cancer, technology advancements in therapeutics, increasing government initiatives globally are expected to drive the growth of the market in the coming years.

Companies Profiled:

Market Leaders:
• Leica Biosystems Nussloch GmbH
• Thermo Fisher Scientific
• F. Hoffmann-La Roche AG
• Abbott Laboratories
• Agilent Technologies
• PerkinElmer
• Qiagen / Exiqon A/S
• Merck KGaA
• BioGenex Laboratories
• BioTechne / Advanced Cell Diagnostics (ACD)

Key Topics:
• In Situ Hybridization
• Molecular Diagnostics
• Cervical Cancer Stain
• Fish Steps Reduction
• Fluorescence In Situ Hybridization (FISH)
• In Situ Hybridization (ISH)
• FISH Probe Kit
• Cancer
• Chromosonal Abnormalities
• Infectious Diseases
• Inflammatory Diseases
• Fluorescence In Situ Hybridization (FISH)
• Chromogenic In Situ Hybridization (CISH)
• Human Genetic Tests
• Microbial Tests
• In Vitro Diagnostics
• System for the Analysis of Solid Tumors
• Hybridization Technique
• Detection of Long Non-
• Coding DNA
• Coding RNA

Browse Full Research Report of Market With TOC @:
https://www.radiantinsights.com/research/in-situ-hybridization-market

Table of Contents:

US In situ Hybridization Executive Summary 15
In Situ Hybridization (ISH) 15

1. United States In Situ Hybridization ISH Market Definition and Market Dynamics 16
   1.1 US In situ Hybridization Market Overview 16
   1.1.1 Antibody Challenges and Validation 16
   1.2 Scope of In situ Hybridization in Inflammation 17
   1.2.1 RNAscope® Applications 17
2. In-Situ Hybridization Market Shares and Market Forecasts 20
   2.1 In-Situ Hybridization Market Driving Forces 20
   2.1.1 Identification of Cytokines and their Cellular Origins 21
   2.1.2 Detection of Long Non-Coding RNA (lncRNA) in Inflammatory Diseases 21
   2.1.3 Role of Inflammatory Pathways During Carcinogenesis 22
   2.1.4 Therapeutic Potential Of Secreted Proteins In Inflammatory Diseases 22
   2.1.5 Dual ISH-IHC Detect Cytokines During Inflammatory Responses 22
   2.2 In Situ Hybridization Market Shares 24
   2.2.1 Roche 25
   2.2.2 Abbott Molecular 25
   2.2.3 Advanced Cell Diagnostics 25

About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street, Suite 3036, San Francisco, CA 94105, United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com